相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antimicrobial Peptides as Potential Therapeutic Agents: A Review
Shreeja Datta et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2021)
Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates
Abolfazl Jahangiri et al.
MICROBIAL PATHOGENESIS (2021)
In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli
Kaitlin S. Witherell et al.
SCIENTIFIC REPORTS (2021)
The Potential of Frog Skin Peptides for Anti-Infective Therapies: The Case of Esculentin-1a(1-21)NH2
Bruno Casciaro et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications
Jaspreet Kaur Boparai et al.
PROTEIN AND PEPTIDE LETTERS (2020)
Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction
Anthony R. M. Coates et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
Ali Pormohammad et al.
MICROBIAL PATHOGENESIS (2020)
A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline inAcinetobacter baumannii
Stamatis Karakonstantis
JOURNAL OF CHEMOTHERAPY (2020)
Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities
Bruno Casciaro et al.
ANTIBIOTICS-BASEL (2020)
In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug ResistantAcinetobacter baumannii
Manoj Jangra et al.
MOLECULES (2020)
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Y. Wu et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
E. -T. Piperaki et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Drug combinations: a strategy to extend the life of antibiotics in the 21 st century
Mike Tyers et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Combinatory Therapy Antimicrobial Peptide-Antibiotic to Minimize the Ongoing Rise of Resistance
Luis R. Pizzolato-Cezar et al.
FRONTIERS IN MICROBIOLOGY (2019)
Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
Angelique Lewies et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa
Serge Ruden et al.
FRONTIERS IN MICROBIOLOGY (2019)
Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome
Bukhari Elham et al.
AFRICAN HEALTH SCIENCES (2019)
Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update
Yamuna Devi Bakthavatchalam et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo
Laszlo Otvos et al.
FRONTIERS IN CHEMISTRY (2018)
Esculentin-1a Derived Antipseudomonal Peptides: Limited Induction of Resistance and Synergy with Aztreonam
Bruno Casciaro et al.
PROTEIN AND PEPTIDE LETTERS (2018)
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Jianguo Li et al.
FRONTIERS IN NEUROSCIENCE (2017)
The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections
Mara Guadalupe Garcia-Patino et al.
FRONTIERS IN IMMUNOLOGY (2017)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Colistin, mechanisms and prevalence of resistance
Abed Zahedi Bialvaei et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections
Matteo Bassetti et al.
CURRENT OPINION IN CRITICAL CARE (2015)
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis
Satya Sree N. Kolar et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species
Tabbene Olfa et al.
FEMS YEAST RESEARCH (2015)
Antimicrobial resistance in Acinetobacter baumannii : From bench to bedside
Ming-Feng Lin et al.
WORLD JOURNAL OF CLINICAL CASES (2014)
Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37
Jennifer H. Moffatt et al.
INFECTION AND IMMUNITY (2013)
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Raffaele Zarrilli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
X. Vila-Farres et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Pranita D. Tamma et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
Nabil Karah et al.
DRUG RESISTANCE UPDATES (2012)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group
J. Michael Conlon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Paul G. Higgins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii
J. F. Turton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality
Effrossyni Gkrania-Klotsas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
分享论文
